Evidence map›Paper›PMID 38398470›Full record

ArticleJournal of clinical medicine2024

Linear IgA Bullous Dermatosis in Korea Using the Nationwide Health Insurance Database.

Yu Rim Kim, Ji Hyeon Kim, Sang Won Kim, Jae Min Lee, Jacob S Bae

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Yu Rim KimDepartment of Medicine, College of Medicine, Yeungnam University, Daegu 42415, Republic of Korea.
Ji Hyeon KimDepartment of Medicine, College of Medicine, Yeungnam University, Daegu 42415, Republic of Korea.
Sang Won KimMedical Research Center, College of Medicine, Yeungnam University, Daegu 42415, Republic of Korea.ORCID 0000-0003-2648-0340
Jae Min LeeDepartment of Pediatrics, College of Medicine, Yeungnam University, Daegu 42415, Republic of Korea.ORCID 0000-0001-6822-1051
Jacob S BaeDepartment of Internal Medicine, College of Medicine, Yeungnam University, Daegu 42415, Republic of Korea.ORCID 0000-0003-0860-4303
Yeungnam University · KRYeungnam University Medical Center · KR

Funding

Yeungnam University 2023 research grant
6 · The paper itself

Abstract

(1) Background: Linear immunoglobulin A bullous dermatosis (LABD) is a rare autoimmune, subepidermal blistering disease, characterized by linear IgA deposits along the epidermal basement membrane. LABD is idiopathic and is associated with medication and systemic autoimmune diseases. (2) Methods: We investigated the demographic characteristics, disease course, causative agents, and associated diseases in Korean patients with LABD. The Korean Health Insurance Review and Assessment Service database was used to obtain data. We identified 670 LABD cases between 2010 and 2022. (3) Results: The annual incidence of LABD was 1.3 per 100,000 persons, with a higher prevalence in individuals ≥60 years old. The patients were treated with dapsone for 30.7 ± 56.7 days, had 1.3 ± 0.7 hospital visits, and were hospitalized for 19.8 ± 19.7 days. Risk factors, including malignancy, commonly preceded LABD. Antibiotic use, specifically vancomycin and third-generation cephalosporins, was a risk factor. The mean age of LABD diagnosis was 55.9 ± 21.7 years. (4) Conclusion: This is the first published study to assess a nationwide cohort for LABD. The incidence of LABD was higher than that in other studies. Most case reports have linked LABD with the administration of specific antibiotics; however, this study shows there were more associations with other conditions.

Indexed as

antibioticsepidemiologyKorealinear immunoglobulin A bullous dermatosis

Identifiers

PMID38398470
PMCPMC10889246
OpenAlexW4391946944

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.